Experienced in Autoimmune Hemolytic Anemia
Experienced in Autoimmune Hemolytic Anemia
3800 Reservoir Rd Nw, 
Washington, DC 
 (703.2 mi)

Overview

Corina Gonzalez is a Pediatric Hematologist Oncology specialist and a Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Gonzalez and is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Factor 5 Deficiency, Clear Cell Sarcoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Autoimmune Hemolytic Anemia.

Specialties
Pediatric Hematology Oncology
Hematology Oncology
Hematology
Licenses
Pediatric Hematology-Oncology in DC
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Locations

3800 Reservoir Rd Nw, Washington, DC 20007

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


14 Clinical Trials

Renal Tumors Classification, Biology, and Banking Study
Neuroblastoma Biology Studies
Umbrella Long-Term Follow-Up Protocol
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
View 9 Less Clinical Trials
Similar Doctors
Elite in Autoimmune Hemolytic Anemia
Hematology Oncology | Hematology | Oncology
Elite in Autoimmune Hemolytic Anemia
Hematology Oncology | Hematology | Oncology

Mgmc LLC

3800 Reservoir Rd Nw, 
Washington, DC 
Experience:
40+ years
Languages Spoken:
English
Accepting New Patients

Catherine Broome is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Broome has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Autoimmune Hemolytic Anemia, Thrombocytopenia, Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Splenectomy. Dr. Broome is currently accepting new patients.

Distinguished in Autoimmune Hemolytic Anemia
Oncology | Hematology | Hematology Oncology
Distinguished in Autoimmune Hemolytic Anemia
Oncology | Hematology | Hematology Oncology

Frederick Health Medical Group LLC

1562 Opossumtown Pike, 
Frederick, MD 
 (40.5 mi)
Languages Spoken:
English
Accepting New Patients

Elhamy Eskander is an Oncologist and a Hematologist in Frederick, Maryland. Dr. Eskander and is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Autoimmune Hemolytic Anemia. Dr. Eskander is currently accepting new patients.

Distinguished in Autoimmune Hemolytic Anemia
Hematology | Oncology
Distinguished in Autoimmune Hemolytic Anemia
Hematology | Oncology

Johns Hopkins University

600 N Wolfe St, Blalock 266, 
Baltimore, MD 
 (37.2 mi)
Languages Spoken:
English
Accepting New Patients

Robert Brodsky is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Brodsky and is rated as an Elite provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile